Delivery Order SPE2DR25D7065-SPE2DR26F8FVZ
- Not listed
- The Defense Logistics Agency awarded a $5,327.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of September 12, 2025, represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework with DLA. This delivery order was competitively awarded with no set-aside designation, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors valued at $5,364.64 under firm fixed-price terms. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive procurement utilizing an existing contract vehicle rather than a new...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,892.41 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Sumatriptan 6 mg/0.5 ml auto-injectors. This competitive, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a continuation of the company's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $2,652.22. This competitively awarded, firm fixed-price delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 8, 2025. The award represents a routine pharmaceutical supply transaction under a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $14,947.67 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction within AmerisourceBergen Drug Corp's broader relationship...
- The Defense Logistics Agency awarded a delivery order valued at $2,187.56 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,127.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,422.85 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DR25D7065Indefinite Delivery Contract
- SPE2DR25D7065-SPE2DR26F8FVZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,451.90 and a firm fixed price. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. As a prime vendor for pharmaceutical and medical supply procurement, AmerisourceBergen supplies a comprehensive portfolio of medications and healthcare commodities to support military and veteran healthcare systems. The IDC serves as the contracting vehicle enabling the company to fulfill federal medical supply needs across multiple therapeutic domains on a global basis, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/14/25 |